AbCellera Biologics Inc.
ABCL
$3.85
$0.071.85%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 760.59M | 785.84M | 795.69M | 796.50M | 886.49M |
| Total Receivables | 64.38M | 37.45M | 45.68M | 99.57M | 103.41M |
| Inventory | 1.11M | 1.19M | 1.45M | 1.45M | 1.53M |
| Prepaid Expenses | 20.91M | 32.00M | 22.36M | 18.14M | 9.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.00M | 63.04M | 65.56M | 25.00M | 25.00M |
| Total Current Assets | 871.99M | 919.52M | 930.74M | 940.65M | 1.03B |
|
|
|||||
| Total Current Assets | 871.99M | 919.52M | 930.74M | 940.65M | 1.03B |
| Net Property, Plant & Equipment | 287.70M | 277.21M | 259.64M | 233.19M | 217.26M |
| Long-term Investments | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Total Other Intangibles | 120.43M | 124.08M | 126.75M | 128.85M | 131.50M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 94.24M | 48.39M | 81.15M | 60.15M | 84.43M |
| Total Assets | 1.49B | 1.51B | 1.54B | 1.50B | 1.54B |
|
|
|||||
| Total Accounts Payable | 25.51M | 17.43M | 21.03M | 17.57M | 14.83M |
| Total Accrued Expenses | 10.80M | 9.45M | 6.95M | 4.89M | 25.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.16M | 5.57M | 5.95M | 5.87M | 5.58M |
| Total Finance Division Other Current Liabilities | 76.55M | 77.79M | 84.97M | 61.27M | 72.11M |
| Total Other Current Liabilities | 76.55M | 77.79M | 84.97M | 61.27M | 72.11M |
| Total Current Liabilities | 119.01M | 110.24M | 118.91M | 89.59M | 118.32M |
|
|
|||||
| Total Current Liabilities | 119.01M | 110.24M | 118.91M | 89.59M | 118.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 71.22M | 75.19M | 78.08M | 77.27M | 76.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 145.54M | 143.99M | 145.36M | 122.56M | 112.64M |
| Total Liabilities | 335.78M | 329.42M | 342.34M | 289.42M | 307.63M |
|
|
|||||
| Common Stock & APIC | 874.25M | 857.30M | 841.18M | 824.45M | 808.48M |
| Retained Earnings | 279.79M | 326.94M | 355.55M | 386.08M | 426.19M |
| Treasury Stock & Other | -1.72M | -1.46M | -1.90M | -2.02M | -1.39M |
| Total Common Equity | 1.15B | 1.18B | 1.19B | 1.21B | 1.23B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.15B | 1.18B | 1.19B | 1.21B | 1.23B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.15B | 1.18B | 1.19B | 1.21B | 1.23B |
|
|
|||||
